INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title:
DEVELOPMENT AND VALIDATION OF LC-MS/MS METHOD FOR SIMULTANEOUS ESTIMATION OF AZELNIDIPINE AND TELMISARTAN IN TABLET AND CHARACTERIZATION OF DEGRADANT BY LC-MS/MS
Authors Name:
Hiral j Prajapati
, Mr. Dhaval Patel , Dr. Chaitanya bhatt , Mr. Nishith Patel , Dr. Vanita Marvaniya
The objective of this study was to explore the degradation behavior of Azelnidipine and Telmisartan under acidic, basic, oxidative, photolytic and thermal stress conditions as per prescribed International Conference on Harmonization (ICH) guidelines. Azelnidipine was found to be liable under acidic and oxidative stress conditions, whereas it was stable under basic, photolytic and thermal stress conditions. Similarly, Telmisartan was found to be liable under acidic and oxidative stress conditions, whereas it was stable under basic, photolytic and thermal stress conditions. A total of two degradation products (DPs) were characterized for azelnidipine and two degradation products (DPs) were characterized for Telmisartan, and their chromatographic separation was accomplished on Hypersil, BDS, C18, (150mm x 4.6mm, 5µm) column using a mobile phase consisting buffer (pH-5) : methanol in isocratic elution mode. The ion transitions were quantified in positive mode with MRM transition of 583.300→496.200 Da for Azelnidipine and 515.100→499.500 Da for Telmisartan. All the stressed sample were subjected to ESI-MS/MS and LCMS/MS analysis. Azelnidipine and Telmisartan and its degradation products were characterized based on MRM scan mode and fragmentation patterns were obtained from ESI-MS/MS spectra. Structural elucidation of DPs of Azelnidipine and Telmisartan was achieved by comparing their fragmentation patterns with that of Azelnidipine and Telmisartan. The developed method has been validated for specificity, linearity, accuracy, precision and robustness as per ICH guideline. The method provided good linearity over the range of 0.4-1.2 μg/ml for Azelnidipine and 2.0-6.0 μg/ml for Telmisartan with short run time of 10 min. The proposed method was successfully applied for the estimation of Azelnidipine and Telmisartan in its pharmaceutical dosage form. The LC-MS/MS method were found to be simple, accurate, robust and reproducible. The assay can can be successfully applied for routine QC analysis.
Keywords:
Azelnidipine, Telmisartan, LC-MS/MS method, Validation, ICH Q2 (R1) guidelines.
Cite Article:
"DEVELOPMENT AND VALIDATION OF LC-MS/MS METHOD FOR SIMULTANEOUS ESTIMATION OF AZELNIDIPINE AND TELMISARTAN IN TABLET AND CHARACTERIZATION OF DEGRADANT BY LC-MS/MS", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 5, page no.g580-g585, May-2023, Available :http://www.ijnrd.org/papers/IJNRD2305673.pdf
Downloads:
000118752
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn